Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06497959
PHASE3

Study of Placental Vascularization Using Contrast Ultrasound

Sponsor: Central Hospital, Nancy, France

View on ClinicalTrials.gov

Summary

Preeclampsia and intrauterine growth restriction (IUGR) are two principal complications of pregnancy. These diseases are related to placental dysfunction nevertheless knowledge of its pathophysiological mechanisms remains inadequate. No etiological treatment for these pathologies is available. Inducing birth is the only way to prevent the occurrence of these complications (such as fetal death in utero. Therefore, a better understanding of placental vascularization under pathological and physiological conditions is necessary. This placental vascularization evolves throughout gestation. Histological studies have improved our knowledge of placental vascular pathologies; however, these are ex vivo data that only provide an incomplete reflection of placental function. In vivo placental studies are therefore essential to understand the mechanisms of placental perfusion. Currently, these studies are limited because the available tools (such as placental Doppler) do not allow for the separate study of maternal placental flow from fetal flow. However, histological evidence clearly establishes maternal placental vascular involvement in IUGR. It would therefore be interesting to study maternal and fetal placental vascularization separately. The development of new in vivo imaging exploration techniques will help to better understand placental pathologies. In obstetrics, CES would offer the opportunity to study in vivo placental vascularization in a segmented manner (maternal versus fetal side independently) since the microbubbles do not cross the placental barrier. Animal studies show no toxic effects on fetal development nor any crossing of the placental barrier. In humans, the innovative use of this contrast agent has allowed for a better understanding of placental vascularization in the first trimester of pregnancy.

Official title: Contribution of Contrast-Enhanced Ultrasound (CES) in the Fetal-placental Circulation Study

Key Details

Gender

FEMALE

Age Range

18 Years - 64 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2025-04-09

Completion Date

2029-04-10

Last Updated

2026-04-07

Healthy Volunteers

No

Interventions

DRUG

SonoVue

Placental contrast ultrasound using SonoVue by maternal intravenous injection

Locations (1)

CHRU de NANCY

Nancy, France